FirmAtlas

Company handbook · MCHP · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17

MCHP · CIK 827054 · LATEST FILING: 10-Q JUN '26 · FILED AUG 6, 2026

MICROCHIP TECHNOLOGY INCORPORATED

$73.85 −0.41 (−0.55%)

Close, Oct 16, 2026 · 52-week $49–106

↗ microchip.com

Last fiscal year

MICROCHIP TECHNOLOGY INCORPORATED reported revenue of $4.7B for the year ended Mar 31, 2026 (FY25), up 7.1% from FY24. Net income was $230M, operating cash flow $962M and free cash flow $871M. Source: 10-K filed May 21, 2026.

Market cap

$40.0B

P/E

83.7

EV/EBITDA

38.4x

P/B

6.2

Div yield

2.46%

ROIC

3.5%

Revenue 1Y

7.1%/yr

EPS 1Y

n/m

Shares 1Y

+0.6%

Loading chart…

Daily closes, split-adjusted · ratios at each fiscal year end

Company

CEOSteve Sanghi

HQChandler, AZ

AuditorErnst & Young LLP

Employees17,900

Year endsMarch

Revenue by segment · FY25

Semiconductor Products97%

Technology Licensing3%

Compounded growth & averages

10Y

TTM

Share price

9.6%

0.3%

−2.2%

13.0%

Upgrade to see 10 years

Share price: yearly compound rate of the traded close; the last column is the past year.

Where the cash went · FY24–FY25

$2.3B deployed

Capex $217M 9.5%

Dividends $2.0B 86.2%

Buybacks $96M 4.2%

Operating cash flow over the period: $1.9B. Total debt changed by −$134M. R&D of $2.1B is already inside operating costs.

Sources 10-K FY25 10-Q Jun '26 All filings on EDGAR

Latest filings

Aug 19, 2026 Executive or director change 8-K Aug 6, 2026 Quarterly results 8-K Jul 24, 2026 Executive or director change 8-K Jun 1, 2026 Executive or director change 8-K May 7, 2026 Quarterly results 8-K

Growth engines

How much of the profit growth came from new investment, and how much from running the business better.

Upgrade to see 10 years

Financials

Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Mar 31, 2026 · change vs previous year

Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier

TTM = the last four quarters, to Jun '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.

Income

FY24 FY25

TTM

Revenue

4,402

4,713+7.1%

5,122

YoY

+7.1%

Gross profit

2,468

2,721+10.3%

3,083

Gross margin

56.1%

57.7%+1.7 pp

—

Operating income

296

490+65.4%

795

Operating margin

6.7%

10.4%+3.7 pp

—

EBITDA

1,046

1,179+12.7%

—

EBITDA margin

23.8%

25.0%+1.3 pp

—

Interest expense

259

221−14.6%

—

Interest coverage

4.04x

5.33x+1.29x

—

Net income

(0.5)

230n/m

478

YoY

n/m

Net margin

−0.0%

4.9%+4.9 pp

—

EPS (diluted, $)

−0.01

0.22n/m

—

YoY

n/m

Balance sheet

FY24 FY25

TTM

Total assets

15,375

14,370−6.5%

14,407

Cash & short-term investments

772

240−68.9%

—

Accounts receivable

690

895+29.7%

—

Inventory

1,294

1,035−20.0%

—

Net PP&E

1,184

1,107−6.5%

—

Other assets

11,436

11,093−3.0%

—

Total liabilities

8,296

7,938−4.3%

7,956

Accounts payable

161

206+28.0%

—

Total debt

5,630

5,496−2.4%

5,361

Other liabilities

2,505

2,236−10.8%

—

Shareholders’ equity

7,078

6,432−9.1%

6,451

Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.

Cash flow statement · as filed

FY24 FY25

TTM

Cash from operations

898

962+7.1%

1,198

Net income

(0.5)

230n/m

—

Depreciation & amortization

750

689−8.1%

—

Stock-based compensation

180

255+41.6%

—

Working capital & other

(32)

(213)n/m

—

Cash from investing

(288)

(196)n/m

—

Capex

(126)

(91)n/m

—

Other investing

(162)

(104)n/m

—

Cash from financing

(158)

(1,298)n/m

—

Debt raised

1,992

0−100.0%

—

Debt repaid

(1,000)

(1,200)n/m

—

Dividends

(976)

(984)n/m

—

Buybacks

(96)

0n/m

—

Shares issued

62−5.7%

—

Other financing

(144)

824n/m

—

Net change in cash

452

(531)−217.6%

—

Free cash flow (OCF − capex)

772

871+12.8%

1,111

Where the cash went

FY24 FY25

TTM

Operating cash flow

898

962+7.1%

1,198

Reinvested in the business

126

91−27.7%

—

% of operating cash flow

14.0%

9.5%

Capex

126

91−27.7%

R&D (memo, already in costs)

984

1,086+10.4%

—

Free cash flow

772

871+12.8%

1,111

YoY

+12.8%

Returned to shareholders

1,072

984−8.2%

—

% of free cash flow

138.9%

113.0%

Dividends

976

984+0.9%

—

Buybacks

0−100.0%

—

Change in total debt

—

(134)

—

Cash left over

—

(247)

—

FCF conversion (FCF ÷ net income)

—

378.7%

—

Owner earnings

—

926

—

Owner earnings margin

—

19.7%

—

Buyback yield

0.4%

—

Returns & ratios

FY24 FY25

TTM

ROIC (all capital)

1.0%

3.5%+2.5 pp

—

ROIC (operating)

3.9%

14.1%+10.2 pp

—

Net debt / EBITDA

4.64x

4.46x−0.19x

—

Debt / equity

0.80x

0.85x+0.06x

—

Cash conversion cycle (days)

271

221−50 d

—

ROE

−0.0%

3.6%+3.6 pp

—

ROA

−0.0%

1.6%+1.6 pp

—

ROCE

2.1%

3.7%+1.6 pp

—

NOPAT

119

412+247.7%

—

Invested capital (operating)

3,006

2,831−5.8%

—

Invested capital (all)

11,937

11,688−2.1%

—

Reinvestment rate

—

−42.5%

—

Debtor days

69+12 d

—

Inventory days

244

190−54 d

—

Days payable

38+7 d

—

Net debt is 4.5x EBITDA (FY25).

Income

Sep '25

Dec '25

Mar '26

Jun '26

Revenue

1,140

1,186

1,311

1,485

vs year-ago quarter

Gross profit

638

707

800

939

Gross margin

55.9%

59.6%

61.0%

63.2%

Operating income

152

217

337

Net income

144

230

vs year-ago quarter

Net margin

3.7%

5.3%

11.0%

15.5%

EPS (diluted, $)

0.03

0.06

0.27

0.37

vs year-ago quarter

Balance sheet

Sep '25

Dec '25

Mar '26

Jun '26

Total assets

14,470

14,326

14,370

14,407

Cash & equivalents

237

251

240

272

Total debt

5,376

5,366

5,496

5,361

Shareholders’ equity

6,696

6,560

6,432

6,451

Cash flow

Sep '25

Dec '25

Mar '26

Jun '26

Operating cash flow

341

257

512

Capex

Free cash flow

319

243

498

vs year-ago quarter